Cargando…
Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686650/ https://www.ncbi.nlm.nih.gov/pubmed/36358211 http://dx.doi.org/10.3390/antibiotics11111556 |
_version_ | 1784835805862166528 |
---|---|
author | Ali, Alaa M. Hill, Harriet J. Elkhouly, Gehad E. Bakkar, Marwa Reda Raya, Nermeen R. Stamataki, Zania Abo-zeid, Yasmin |
author_facet | Ali, Alaa M. Hill, Harriet J. Elkhouly, Gehad E. Bakkar, Marwa Reda Raya, Nermeen R. Stamataki, Zania Abo-zeid, Yasmin |
author_sort | Ali, Alaa M. |
collection | PubMed |
description | Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria and viruses. However, their frequent administration during COVID-19 pandemic was associated with serious hazards, such as skin toxicity, including irritation, skin dermatitis, skin dryness or cracking, along with peeling redness or itching, with the higher possibility of getting infections. Thus, there is a need to find alternative and novel approaches for hand sanitation. In our previous publications, we reported that rhamnolipids nano-micelles had a comparable antibacterial activity to alcohol-based hand sanitizer and a lower cytotoxicity against human dermal fibroblast cells. In the current study, we investigated the antiviral activity of rhamnolipids nano-micelles against SARS-CoV-2. There was no cytotoxic effect on Vero cells noted at the tested concentrations of rhamnolipids nano-micelles. The rhamnolipids nano-micelles solution at 20, 78, and 312 µg/mL all demonstrated a significant (p < 0.05) decrease of virus infectivity compared to the virus only and the blank vehicle sample. In addition, an acute irritation test was performed on rabbits to further ascertain the biosafety of rhamnolipids nano-micelles. In the eye and skin irritation tests, no degree of irritation was recorded after topical application of rhamnolipids nano-micelles. In addition, histopathological, biomarker, and hematological analyses from animals treated with rhamnolipids nano-micelles were identical to those recorded for untreated animal. From the above, we can conclude that rhamnolipids nano-micelles are a good candidate to be used as a hand sanitizer instead of alcohol-based hand sanitizers. However, they must still be tested in the future among healthcare workers (HCW) in a health care setting to ascertain their antimicrobial efficacy and safety compared to alcohol-based hand sanitizers. |
format | Online Article Text |
id | pubmed-9686650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96866502022-11-25 Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits Ali, Alaa M. Hill, Harriet J. Elkhouly, Gehad E. Bakkar, Marwa Reda Raya, Nermeen R. Stamataki, Zania Abo-zeid, Yasmin Antibiotics (Basel) Article Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria and viruses. However, their frequent administration during COVID-19 pandemic was associated with serious hazards, such as skin toxicity, including irritation, skin dermatitis, skin dryness or cracking, along with peeling redness or itching, with the higher possibility of getting infections. Thus, there is a need to find alternative and novel approaches for hand sanitation. In our previous publications, we reported that rhamnolipids nano-micelles had a comparable antibacterial activity to alcohol-based hand sanitizer and a lower cytotoxicity against human dermal fibroblast cells. In the current study, we investigated the antiviral activity of rhamnolipids nano-micelles against SARS-CoV-2. There was no cytotoxic effect on Vero cells noted at the tested concentrations of rhamnolipids nano-micelles. The rhamnolipids nano-micelles solution at 20, 78, and 312 µg/mL all demonstrated a significant (p < 0.05) decrease of virus infectivity compared to the virus only and the blank vehicle sample. In addition, an acute irritation test was performed on rabbits to further ascertain the biosafety of rhamnolipids nano-micelles. In the eye and skin irritation tests, no degree of irritation was recorded after topical application of rhamnolipids nano-micelles. In addition, histopathological, biomarker, and hematological analyses from animals treated with rhamnolipids nano-micelles were identical to those recorded for untreated animal. From the above, we can conclude that rhamnolipids nano-micelles are a good candidate to be used as a hand sanitizer instead of alcohol-based hand sanitizers. However, they must still be tested in the future among healthcare workers (HCW) in a health care setting to ascertain their antimicrobial efficacy and safety compared to alcohol-based hand sanitizers. MDPI 2022-11-04 /pmc/articles/PMC9686650/ /pubmed/36358211 http://dx.doi.org/10.3390/antibiotics11111556 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ali, Alaa M. Hill, Harriet J. Elkhouly, Gehad E. Bakkar, Marwa Reda Raya, Nermeen R. Stamataki, Zania Abo-zeid, Yasmin Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits |
title | Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits |
title_full | Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits |
title_fullStr | Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits |
title_full_unstemmed | Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits |
title_short | Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits |
title_sort | rhamnolipid nano-micelles inhibit sars-cov-2 infection and have no dermal or eye toxic effects in rabbits |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686650/ https://www.ncbi.nlm.nih.gov/pubmed/36358211 http://dx.doi.org/10.3390/antibiotics11111556 |
work_keys_str_mv | AT alialaam rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits AT hillharrietj rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits AT elkhoulygehade rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits AT bakkarmarwareda rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits AT rayanermeenr rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits AT stamatakizania rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits AT abozeidyasmin rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits |